Vir Biotechnology Inc (VIR)
Return on assets (ROA)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | -521,960 | -615,061 | 515,837 | 528,584 | -298,665 |
| Total assets | US$ in thousands | 1,398,810 | 1,919,060 | 2,802,090 | 1,954,270 | 918,761 |
| ROA | -37.31% | -32.05% | 18.41% | 27.05% | -32.51% |
December 31, 2024 calculation
ROA = Net income ÷ Total assets
= $-521,960K ÷ $1,398,810K
= -37.31%
Based on the return on assets (ROA) data provided for Vir Biotechnology Inc, the company experienced significant fluctuations in its ROA over the years.
- As of December 31, 2020, the ROA was -32.51%, indicating that for every dollar of assets, the company incurred a loss.
- By December 31, 2021, the ROA improved significantly to 27.05%, indicating that the company generated a strong return on its assets.
- The ROA decreased to 18.41% by December 31, 2022, suggesting a slight decline in the company's efficiency in generating profits from its assets.
- However, by December 31, 2023, the ROA turned negative again at -32.05%, indicating that the company experienced a decline in profitability relative to its assets.
- The negative trend continued by December 31, 2024, with a further decrease in ROA to -37.31%, illustrating a decrease in the company's ability to generate profits from its assets.
Overall, the fluctuating ROA values suggest that Vir Biotechnology Inc has been facing challenges in efficiently utilizing its assets to generate returns, with periods of profitability followed by periods of decline. The company may need to assess and address the factors contributing to these fluctuations to improve its financial performance and profitability in the future.
Peer comparison
Dec 31, 2024